News

On Friday, the FDA and the Reagan-Udall Foundation for the FDA announced a public meeting on October 4 titled, “Mitigating Risks from Human Xylazine Exposure”.  Read more

The Reagan-Udall Foundation plans to release a commissioner-requested report on Oct. 5 — as long as the federal government doesn’t shut down — outlining how the FDA can more effectively combat misinformation, the group’s leader said this week. Read…

Research Director Carla Rodriguez Watson, PhD, MPH continues the RAISE conversation about race and ethnicity data in healthcare.  Listen to the podcast

Host Niasha Fray welcomes Carla Rodriguez-Watson, PhD, MPH, FDA Foundation Director of Research to discuss improving the collection and curation of race and ethnicity data in health care. They discuss challenges and explore solutions.…

The second in a series of podcasts on improving clinical trial access to diverse populations. The September 15 episode features FDA Foundation Research Director Carla Rodriguez-Watson, PhD, MPH as she, and others, discuss potential solutions.…

The Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM) is seeking public comment on a report outlining a potential framework for establishing a public-private partnership (PPP) to collect and analyze antimicrobial use (…

In a sizable step toward reorganizing the Human Foods Program (HFP or Program) to rehaul the US Food and Drug Administration’s (FDA’s) current food infrastructure to better coordinate the agency’s regulation of food products, FDA announced the…

On OMHHE’s latest podcast, FDA Foundation’s CEO, Susan Winckler, RPh, Esq. and Research Director, Carla Rodriguez-Watson, PhD, MPH, discuss the RAISE, a project to improve the capture and curation of race & ethnicity data in health care—and the…

Both of us have dedicated our careers to advancing food safety and protecting the public. We’ve both done so at the height of federal service, in academic settings, as well as within the private sector. That’s why we believe we’re well qualified to…

Today, the U.S. Food and Drug Administration issued warning letters to three infant formula manufacturers as part of the agency’s ongoing commitment to enhance regulatory oversight to help ensure that the industry is producing infant formula under the…